Data / Form D filings / RVL Pharmaceuticals plc
RVL Pharmaceuticals plc: Form D filing
RVL Pharmaceuticals plc, a pharmaceuticals company in Bridgewater, NJ, filed a Form D with the SEC in 2023. The latest, on August 31, 2023, reports $5 million sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 CROSSING BOULEVARD, Bridgewater, NJ, 08807
- Phone
- (908) 809-1300
- Industry
- Pharmaceuticals
- Entity type
- Other (IRISH LIMITED COMPANY)
- Incorporated in
- Ireland
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1739426
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2023 | New notice | $5,000,000 | $5,000,000 | 1 | Aug 18, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| BRIAN MARKISON | Executive Officer, Director | |
| GREGORY COWAN | Director | |
| JUAN VERGEZ | Director | |
| JOAQUIN BENES | Director | |
| MICHAEL DEBIASI | Director | |
| ALISA LASK | Director | |
| JAMES SCHAUB | Executive Officer |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Aug 28, 2023 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what RVL Pharmaceuticals plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.